BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37420249)

  • 1. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
    Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
    Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
    Jiao W; Atwal G; Polak P; Karlic R; Cuppen E; ; Danyi A; de Ridder J; van Herpen C; Lolkema MP; Steeghs N; Getz G; Morris QD; Stein LD;
    Nat Commun; 2020 Feb; 11(1):728. PubMed ID: 32024849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
    Ramarao-Milne P; Kondrashova O; Patch AM; Nones K; Koufariotis LT; Newell F; Addala V; Lakis V; Holmes O; Leonard C; Wood S; Xu Q; Mukhopadhyay P; Naeini MM; Steinfort D; Williamson JP; Bint M; Pahoff C; Nguyen PT; Twaddell S; Arnold D; Grainge C; Basirzadeh F; Fielding D; Dalley AJ; Chittoory H; Simpson PT; Aoude LG; Bonazzi VF; Patel K; Barbour AP; Fennell DA; Robinson BW; Creaney J; Hollway G; Pearson JV; Waddell N
    ESMO Open; 2022 Aug; 7(4):100540. PubMed ID: 35849877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
    Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
    Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning for cancer type classification and driver gene identification.
    Zeng Z; Mao C; Vo A; Li X; Nugent JO; Khan SA; Clare SE; Luo Y
    BMC Bioinformatics; 2021 Oct; 22(Suppl 4):491. PubMed ID: 34689757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNN-Boost: Somatic mutation identification of tumor-only whole-exome sequencing data using deep neural network and XGBoost.
    Maruf FA; Pratama R; Song G
    J Bioinform Comput Biol; 2021 Dec; 19(6):2140017. PubMed ID: 34895111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data.
    Ding J; Bashashati A; Roth A; Oloumi A; Tse K; Zeng T; Haffari G; Hirst M; Marra MA; Condon A; Aparicio S; Shah SP
    Bioinformatics; 2012 Jan; 28(2):167-75. PubMed ID: 22084253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
    Vural S; Wang X; Guda C
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):62. PubMed ID: 27587275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
    Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CPEM: Accurate cancer type classification based on somatic alterations using an ensemble of a random forest and a deep neural network.
    Lee K; Jeong HO; Lee S; Jeong WK
    Sci Rep; 2019 Nov; 9(1):16927. PubMed ID: 31729414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined burden and functional impact tests for cancer driver discovery using DriverPower.
    Shuai S; ; Gallinger S; Stein LD;
    Nat Commun; 2020 Feb; 11(1):734. PubMed ID: 32024818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging patterns of somatic mutations in cancer.
    Watson IR; Takahashi K; Futreal PA; Chin L
    Nat Rev Genet; 2013 Oct; 14(10):703-18. PubMed ID: 24022702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DeepSSV: detecting somatic small variants in paired tumor and normal sequencing data with convolutional neural network.
    Meng J; Victor B; He Z; Liu H; Jiang T
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33164053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer whole-genome analyses of metastatic solid tumours.
    Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
    Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding whole-genome mutational signatures in 37 human pan-cancers by denoising sparse autoencoder neural network.
    Pei G; Hu R; Dai Y; Zhao Z; Jia P
    Oncogene; 2020 Jul; 39(27):5031-5041. PubMed ID: 32528130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
    Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM
    BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate Ensemble Prediction of Somatic Mutations with SMuRF2.
    Huang W; Sim NL; Skanderup AJ
    Methods Mol Biol; 2022; 2493():53-66. PubMed ID: 35751808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
    Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
    Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving robust somatic mutation detection with deep learning models derived from reference data sets of a cancer sample.
    Sahraeian SME; Fang LT; Karagiannis K; Moos M; Smith S; Santana-Quintero L; Xiao C; Colgan M; Hong H; Mohiyuddin M; Xiao W
    Genome Biol; 2022 Jan; 23(1):12. PubMed ID: 34996510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.